Goldberg Andrew D.
Insider CIK 1827722 · TARS Director · ACHV CEO and President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 3,837 | — | $0 | 3,837 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 2,417 | — | $0 | 2,417 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-06-12 | 2026-06-16 | 2,954 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-06-12 | 2026-06-16 | 2,954 | — | $0 | 19,654 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-04-18 | 2026-04-21 | 3,601,929 | — | $0 | 3,601,929 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-04-18 | 2026-04-21 | 11,706,270 | — | $0 | 11,706,270 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-04-18 | 2026-04-21 | 1,800,965 | — | $0 | 1,800,965 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-06-13 | 2025-06-16 | 3,350 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-06-13 | 2025-06-16 | 3,350 | — | $0 | 16,700 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 2,954 | — | $0 | 2,954 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 4,540 | — | $0 | 4,540 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-07 | 2025-03-11 | 7,000 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-07 | 2025-03-11 | 7,000 | $12.89 | $90.2K | 13,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-06-24 | 2024-06-25 | 3,350 | — | $0 | 6,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 3,350 | — | $0 | 3,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | P Buy | 2023-12-15 | 2023-12-19 | 1,000 | $18.96 | $19.0K | 3,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 3,350 | — | $0 | 3,350 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-06-22 | 2023-06-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-06-16 | 2023-06-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-06-16 | 2022-07-01 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |